High ability to analyze injuries of the skin inside your office
Spectra-Scope® is a high-precision handheld device for skin cancer diagnosis. The analysis is performed from biochemical information in dermal tissue using laser-induced plasma spectroscopy (LIPS).
Accuracy of early diagnosis
Lesions analyzed by Spectra-Scope® are more likely correctly diagnosed as positive on biopsies.
Faster, more efficiently
Visual examination of injuries takes time and can be challenger. Spectra-Scope® can detect and analyze the most difficult injuries, accurately in seconds.
Fewer biopsies, more treatment control
Spectra-Scope® is able to identify skin lesions more difficult with unique acuity. Thus, the evaluation clinic becomes more efficient and safer.
Basal Cell Carcinoma
Squamous cell carcinoma
Cutaneous T-cell lymphoma
Biochemical analysis in seconds
Detection of skin cancer based on Deep Learning
Very quick procedure, easy and safe
Maximum precision in sensitivity and specificity
97.6% sensitivity and 86.2% specificity
Unprecedented diagnostic accuracy
Spectra-Scope® diagnostic accuracy has been proven by clinical studies conducted worldwide. Is today benefit thousands of doctors and patients in the treatment and skin cancer prevention.
The LIPS metric reflects the degree of atypia in an injury and indicates the risk of malignancy of the skin lesion. THE detection of LIPS on a scale of 0 to 10 provides the physician essential information to determine the course of treatment.
Biochemical information induced by the spectrum of lasers are compared in a vast database of injuries cutaneous. This parameterization is controlled by an algorithm of deep learning that ensures the accuracy of diagnosis each more and more accurate.